Roche Among EU Fast-Track Hopefuls With Lymphoma Bispecific Mosunetuzumab

 
• By Neena Brizmohun
  
The EMA can review marketing applications faster under its accelerated assessment mechanism • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography